Daily AI-curated articles on clinical trials, FDA updates, and pharmaceutical insights.
Dexcom's Stelo becomes the first over-the-counter continuous glucose monitor cleared for children aged 2+ without insulin dependence, marking a significant shift in diabetes care.
FDA issues early alert for Hamilton Medical breathing circuits with potential obstruction risks that could compromise patient ventilation during critical care.
A new atherosclerotic cardiovascular disease trial in Thousand Oaks offers first-of-its-kind investigational therapy for patients with recent cardiac events or diabetes.
Eli Lilly presents compelling clinical data positioning orforglipron as a superior oral alternative to existing GLP-1 therapies for Type 2 diabetes management.
FDA issues warnings to retailers selling illegal tobacco products disguised as common items, raising concerns for clinical researchers studying nicotine addiction.
GE HealthCare's infant resuscitation systems face critical oxygen concentration delivery issues due to faulty blender knobs, prompting FDA safety alert.
New Type 2 diabetes research in Austin evaluates investigational add-on medication for patients with persistent hyperglycemia despite stable treatment regimens.
Eli Lilly and Boehringer Ingelberg each slash $1B+ investments in Germany following healthcare reform targeting branded drug prices, signaling industry-wide concerns.
